Location: Home
  • search
  • go
  • Relate News
  • 8/21/2025Novo Nordisk Meets NHC Minister to Strengthen Collaboration
  • 8/21/2025China Intensifies Biotech Support Amid Surge in Global Licensing Deals
  • 8/21/2025Anixa Secures First Chinese Patent for Breast Cancer Vaccine Technolog...
  • 8/20/2025Pfizer Advances Pneumococcal Vaccine Development in China with Phase 1...
  • 8/20/2025Vivatides Secures Major Seed Funding to Propel Breakthrough in Oligonu...
  • 8/20/2025China Drives Asia-Pacific Health Care Transformation Amid Rising Costs...
  • 8/20/2025On the Cusp of a Cure: Is Asia Pacific Ready for the Precision Era? (C...
  • 8/19/2025U.S. Tariffs Pressure Mounting, Japanese Pharma Looks East for Growth ...
  • 8/19/2025Adjudication Of Drug Patent Linkage Cases When The Originator Drug's T...
  • 8/19/2025Leaving China Manufacturing: The Hidden Risks And How To Protect Your ...
  • 8/19/2025Six Key Insights Into China Biotech's NewCo Model (Mondaq)
  • 8/19/2025CANbridge Announces Strategic Partnership and Investment from Baheal 
  • 8/19/2025BioNTech's BNT327 Shows Strong Phase II Results as China-Originated Dr...
  • 8/19/2025RemeGen and Santen Enter into Licensing Deal for Ophthalmic Drug RC28-...
  • 8/19/2025Aeonvital Biomedical Advances Personalized Cancer Therapies with New F...
  • 8/19/2025Innovent Presents Phase 2 Study of Tarlatamab in Third-Line ES-SCLC at...
  • 8/19/2025China Unveils Nine Key Healthcare Insurance Priorities for 2025
  • 8/19/2025CSPC Pharma Advances in Biosimilars with Dupilumab Injection Approval
  • 8/19/2025Onconic's GERD Drug Jaqbo Advances in China Following Phase 3 Success
  • 8/19/2025Eisai Launches First Orexin Receptor Antagonist for Insomnia in China
  • 8/18/2025Tarlatamab Shows Promising Results in Chinese Phase 2 Trial for Heavil...
  • 8/18/2025Latticon Completes Series A Financing to Advance Trial of LAT010 Immun...
  • 8/18/2025Aoda Raises CNY30M Series A to Advance Dual-Receptor Agonist Program
  • 8/18/2025Yixuan Secures Angel Financing to Advance Novel Nucleic Acid Drug Deve...
  • 8/18/2025Pleryon Completes First Closing of Series A Financing
  • 8/15/2025Guangzhou Innogen Pharma Debuts on HKSE Amid Expanding Metabolic Pipel...
  • 8/15/2025NHSA Issues Interim Measures for Disease-Based Medical Insurance Payme...
  • 8/14/2025ArkBio's Ziresovir Included into Pediatric RSV Drug Priority List by W...
  • 8/14/2025Amphastar Strikes Major Licensing Deal to Supercharge Peptide Pipeline
  • 8/14/2025Innovent's U.S. Unit Fortvita Launches Phase 1 Trial of Oral GLP-1 Ago...
  • Page:18/802 Total number of articles:24041: [First][<<] [16] [17] [18] [19] [20] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group